Prodrug Approach for Increasing Cellular Glutathione Levels
Open Access
- 3 March 2010
- Vol. 15 (3), 1242-1264
- https://doi.org/10.3390/molecules15031242
Abstract
Reduced glutathione (GSH) is the most abundant non-protein thiol in mammalian cells and the preferred substrate for several enzymes in xenobiotic metabolism and antioxidant defense. It plays an important role in many cellular processes, such as cell differentiation, proliferation and apoptosis. GSH deficiency has been observed in aging and in a wide range of pathologies, including neurodegenerative disorders and cystic fibrosis (CF), as well as in several viral infections. Use of GSH as a therapeutic agent is limited because of its unfavorable biochemical and pharmacokinetic properties. Several reports have provided evidence for the use of GSH prodrugs able to replenish intracellular GSH levels. This review discusses different strategies for increasing GSH levels by supplying reversible bioconjugates able to cross the cellular membrane more easily than GSH and to provide a source of thiols for GSH synthesis.Keywords
This publication has 139 references indexed in Scilit:
- Glutathione dysregulation and the etiology and progression of human diseasesBiological Chemistry, 2008
- Inborn errors in the metabolism of glutathioneOrphanet Journal of Rare Diseases, 2007
- Characterization of intracellular elevation of glutathione (GSH) with glutathione monoethyl ester and GSH in brain and neuronal cultures: Relevance to Parkinson's diseaseExperimental Neurology, 2007
- In vitro and in vivo neuroprotection by γ-glutamylcysteine ethyl ester against MPTP: Relevance to the role of glutathione in Parkinson's diseaseNeuroscience Letters, 2006
- Gender differences in glutathione metabolism in Alzheimer's diseaseJournal of Neuroscience Research, 2005
- Effects of S-acetylglutathione in cell and animal model of herpes simplex virus type 1 infectionMedical Microbiology and Immunology, 2003
- Therapeutic potential of N-acetylcysteine in age-related mitochondrial neurodegenerative diseasesMedical Hypotheses, 2001
- Amino acids, glutathione, and glutathione transferase activity in the brains of patients with Alzheimer's diseaseAnnals of Neurology, 1987
- 2-Substituted thiazolidine-4(R)-carboxylic acids as prodrugs of L-cysteine. Protection of mice against acetaminophen hepatotoxicityJournal of Medicinal Chemistry, 1984
- POSSIBLE INFLUENCE OF GLUTATHIONE ON POSTISCHEMIC LIVER INJURYActa Pathologica Microbiologica Scandinavica Series A :Pathology, 1984